MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it-Reference-Cited by-同舟云学术

MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it

Published:2020-04 Issue: Volume:145 Page:101-108
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Li Wang-Zhong^ORCID,Liu Guo-Ying,Lin Lan-Feng,Lv Shu-Hui,Qiang Meng-Yun,Lv Xing,Wu Yi-Shan,Liang Hu,Ke Liang-Ru,Wang De-Ling,Yu Ya-Hui,Qiu Wen-Ze,Liu Kui-Yuan,Guo Xiang,Li Jian-Peng,Zou Yu-Jian,Xiang Yan-Qun,Xia Wei-Xiong

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference25 articles.

1. Nasopharyngeal carcinoma;Chua;Lancet,2016

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

3. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines;Gregoire;Radiother Oncol,2014

4. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories;Ma;Clin Cancer Res,2007

5. AJCC cancer staging manual (7th ed.),2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of concurrent chemoradiotherapy with or without Endostar on the regression of retropharyngeal lymph node and prognosis of patients with locally advanced nasopharyngeal carcinoma: a retrospective study;Journal of Cancer Research and Clinical Oncology;2024-05-04

2. Endonasopharyngeal ultrasound and magnetic resonance imaging features of recurrent retropharyngeal nodes in nasopharyngeal carcinoma patients: A radiologic-histopathologic study;Radiotherapy and Oncology;2023-06

3. Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose;BMC Cancer;2023-05-06

4. Significance of Dynamic Changes of VCA-IgA Levels in Pre- and Post-treatment Plasma of Patients with Nasopharyngeal Carcinoma: Development of a Clinically-Oriented Model;Advances in Therapy;2023-03-25

5. Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma;Frontiers in Immunology;2023-02-13